NASDAQ: NEXI - NexImmune, Inc.

Rentabilidad a seis meses: -99.98%
Rendimiento de dividendos: 0.00%
Sector: Healthcare

Calendario de promoción NexImmune, Inc.

Horario avanzado gráfico sencillo
Financial Markets by TradingView

Acerca de la empresa NexImmune, Inc.

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.

más detalles
The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.
Añadir a la lista de comparación
Añadir a la lista de vigilancia
Añadir al portafolio
Añadir aviso de precio

IPO date 2021-02-12
ISIN US65344D1090
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.neximmune.com
Цена ао 0.1
Cambio de precio por día: -99.9% (0.1)
Cambio de precio por semana.: -99.9% (0.1)
Cambio de precio por mes: -99.9% (0.1)
Cambio de precio en 3 meses.: -99.98% (0.41)
Cambio de precio en seis meses: -99.98% (0.51)
Cambio de precio por año: -100% (6.19)
Cambio de precio en 3 años.: -100% (2.35)
Cambio de precio en 5 años.: 0% (0.0001)
Cambio de precio en 10 años.: 0% (0.0001)
Cambio de precio desde principios de año.: -99.96% (0.232)
Todos los parámetros

Subestimación

Nombre Significado Calificación
P/S 0 0
P/BV 0.6519 10
P/E 0 0
EV/EBITDA 0.03 10
Total: 5

Eficiencia

Nombre Significado Calificación
ROA, % -376.36 0
ROE, % -921.57 0
Total: 0

Dividendos

Nombre Significado Calificación
Div yield, % 0 0
DSI 0 0
Total: 0

Deber

Nombre Significado Calificación
Debt/EBITDA -0.0024 10
Total: 10

Impulso de crecimiento

Nombre Significado Calificación
Rentabilidad Revenue, % 0 0
Rentabilidad Ebitda, % 38.08 5
Rentabilidad EPS, % -21.5 0
Total: 3.8
Más detalles

Instituciones Volumen Compartir, %
Slate Path Capital, LP 37000 0.27
Adage Capital Partners GP L.L.C. 32055 0.23
Allen Operations LLC 25437 0.18
EPIQ Capital Group, LLC 15624 0.11
PNC Financial Services Group, Inc. 12640 0.09
First Manhattan Company 5964 0.04
M28 Capital Management LP 5338 0.04
Geode Capital Management, LLC 4326 0.03
Vanguard Group Inc 3893 0.03
Comerica Bank 3257 0.02

ETFCompartir, %Rentabilidad del año, %Dividendos, %
Global X FinTech ETF 2.55324 35.25 0.41722
Fidelity Crypto Industry and Digital Payments ETF 1.77325 86.4 0.10824
VanEck Morningstar International Moat ETF 0.87917 4.7 4.00225
Fidelity MSCI Financials Index ETF 0.18683 33.32 6.52217
Dimensional International Small Cap Value ETF 0.16846 7.13 4.55441
Dimensional International Small Cap ETF 0.14931 5.69 3.34747
Pacer Trendpilot European Index ETF 0.09857 4.01 3.84163
Xtrackers MSCI Eurozone Hedged Equity ETF 0.06037 13.14 3.86046
Franklin FTSE Europe ETF 0.04722 8.4 3.62341
Xtrackers MSCI EAFE ESG Leaders Equity ETF 0.04697 12.02 3.09662
Schwab Fundamental International Small Co. Index ETF 0.04559 8.31 3.46652
IQ FTSE International Equity Currency Neutral ETF 0.04557 11.13 3.27351
JPMorgan BetaBuilders Europe ETF 0.03938 5.19 3.612
Invesco FTSE RAFI Developed Markets ex-U.S. ETF 0.03352 6.19 4.35956
SPDR Portfolio Europe ETF 0.02974 8.94 3.66537
IQ Candriam International Equity ETF 0.02939 10.11 3.0914
Schwab International Equity ETF 0.02538 5.11 3.33884
SPDR MSCI EAFE Fossil Fuel Free ETF 0.02519 11.72 3.25496
JPMorgan BetaBuilders International Equity ETF 0.02489 4.72 3.37709
Xtrackers MSCI EAFE Hedged Equity ETF 0.02422 14.64 3.38114
Dimensional International Core Equity Market ETF 0.02244 13.09 3.48343
Dimensional World ex U.S. Core Equity 2 ETF 0.02227 13.06 3.62488
Vanguard ESG International Stock ETF 0.02 6.39 3.07501
Goldman Sachs MarketBeta International Equity ETF 0.01938 5.33 3.36845
Dimensional International Core Equity 2 ETF 0.01883 6.52 3.69996
Dimensional International Value ETF 0.01883 12.76 5.00468
BNY Mellon International Equity ETF 0.01541 11.1 3.33394
Xtrackers MSCI All World ex US Hedged Equity ETF 0.0146 18.18 3.26685
Global X S&P 500 Catholic Values Custom ETF 0.01315 24.56 1.82969
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund 0.01024 5.17 3.85434
John Hancock Multifactor Developed International ETF 0.00961 3.14 3.77711
FlexShares STOXX Global ESG Select Index Fund 0.00954 14.99 2.18372
Xtrackers FTSE Developed ex US Multifactor ETF 0.00919 10.67 3.53946
SPDR Portfolio Developed World ex-US ETF 0.00699 5.29 3.28401
Xtrackers MSCI Kokusai Equity ETF 0.00663 20.65 1.971
iShares MSCI ACWI ETF 0.00311 -19.68 2.10908
Avantis International Equity ETF 0.00179 6.46 3.80856
0.1812.263.33



Supervisor Título profesional Pago año de nacimiento
Mr. John Trainer M.B.A. Consultant 1.33M 1974 (51 año)
Dr. Daniel P. Bednarik Senior Vice President of Molecular Engineering & Protein Design N/A
Dr. Robert Douglas Knight M.D. Chief Medical Officer 454.77k 1951 (74 año)
Mr. Chad Rubin Senior Vice President of Corporate Affairs N/A
Dr. Jack A. Ragheb M.D., Ph.D. Senior Vice President of Translational Science N/A
Mr. Matthew Schiller Head of Business Development N/A
Mr. Craig R. Jalbert CIRA President, Treasurer, CS, Principal Executive Officer, Financial Off, & Principal Accounting Off 1962 (63 año)
Ms. Karen Haslbeck Head of Human Resources

DIRECCIÓN: United States, Gaithersburg. MD, 9119 Gaither Road - abrir en mapas de google, abrir mapas de Yandex
Sitio web: https://www.neximmune.com